1-(4-tert-butylphenyl)propan-2-one

We are 1-(4-tert-butylphenyl)propan-2-one CAS:81561-77-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-(4-tert-butylphenyl)propan-2-one
CAS.NO:81561-77-5
Synonyms:1-(4-tert-butylphenyl)propan-2-one
4-t-butylphenylacetone
1-(4-tert-butylphenyl)-2-propanone
1-[4-(1,1-dimethylethyl)phenyl]-2-propanone
p-tert-butylphenylacetone
2-Propanone,1-[4-(1,1-dimethylethyl)phenyl]
 
Physical and Chemical Properties:
Molecular Formula C13H18O
Molecular Weight 190.28100
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fenpropimorph(CAS:67306-03-0).

1-(4-tert-butylphenyl)propan-2-one


Related News: Under the strict supervision of environmental protection, it has helped the API industry to continuously optimize its product structure, realize industrial upgrading, and transition to the development of high-end APIs.N- (5-cloropiridin-2-il) -5-metoxi-2-nitrobenzamida CAS:280773-16-2 The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.1-Bromo-6-fluorohexane Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.Diethyl [(2-chloroethoxy)methyl]phosphonate Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.”This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.

Related Products
Product Name
cyclohexyl prop-2-enoate View Details
3-methylthiopropanal View Details
6-Ethyl-3-oxa-6-azaoctanol View Details
(1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate manufacturer 1-Methoxy-2-(trifluoromethoxy)benzene manufacturer 5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2′,3′-diacetate manufacturer Vitamin C Ethyl Ether manufacturer 3-Ethoxy-4-methoxybenzonitrile manufacturer